Correlation Between Elevation Oncology and Immutep

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Immutep at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Immutep into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Immutep Limited, you can compare the effects of market volatilities on Elevation Oncology and Immutep and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Immutep. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Immutep.

Diversification Opportunities for Elevation Oncology and Immutep

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Elevation and Immutep is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Immutep Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immutep Limited and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Immutep. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immutep Limited has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Immutep go up and down completely randomly.

Pair Corralation between Elevation Oncology and Immutep

If you would invest  69.00  in Elevation Oncology on September 13, 2024 and sell it today you would lose (2.00) from holding Elevation Oncology or give up 2.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Elevation Oncology  vs.  Immutep Limited

 Performance 
       Timeline  
Elevation Oncology 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Elevation Oncology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical and fundamental indicators, Elevation Oncology showed solid returns over the last few months and may actually be approaching a breakup point.
Immutep Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immutep Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Elevation Oncology and Immutep Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elevation Oncology and Immutep

The main advantage of trading using opposite Elevation Oncology and Immutep positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Immutep can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will offset losses from the drop in Immutep's long position.
The idea behind Elevation Oncology and Immutep Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets